Skip to content

Author

Hao Liu

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

GLP-1 Receptor Agonist-Based Prandial Insulin De-Intensification in Outpatients With Type 2 Diabetes Receiving Basal-Bolus Insulin Therapy or Multiple Daily Injections: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

AIMS This systematic review and meta-analysis aimed to compare GLP-1 receptor agonist (GLP-1RA)-based prandial insulin de-intensification with continued basal-bolus insulin therapy (BBI) or multiple daily injections (MDI) in adult outpatients with type 2 diabetes receiving established BBI/MDI at randomisation. MATERI...

Hong-Xia Yang, Tian-Li Ren, Jin Zhou et al. · 0 citations
Open access Aug 2026

Hemodynamic phenotypes defined by arterial stiffness index and pulse pressure with risk of diabetic microvascular complications in type 2 diabetes

Hemodynamic phenotypes defined by ASI and PP were associated with differential risks of DMC in T2D, and distinct associations of ASI and PP suggest heterogeneous hemodynamic pathways underlying DMC.

Ao-Chuan Sun, Hao Liu, Xu-Sheng Yang et al. · 0 citations
Open access Aug 2026

New insights into lysosomal ferroptosis-related prognostic signatures in prostate cancer: evidence from bulk and single-cell transcriptomic analysis

A novel and potentially useful lysosomal ferroptosis-related prognostic risk model that effectively stratified PRAD patients by survival outcome and therapeutic response is presented, providing a valuable framework for personalized clinical decision-making.

Xudong Zhu, Xi-Xi Ji, Hao Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.